U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    ANTXR2 ANTXR cell adhesion molecule 2 [ Homo sapiens (human) ]

    Gene ID: 118429, updated on 3-Jun-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Investigating the Influence of ANTXR2 Gene Mutations on Protective Antigen Binding for Heightened Anthrax Resistance.

    Investigating the Influence of ANTXR2 Gene Mutations on Protective Antigen Binding for Heightened Anthrax Resistance.
    Archana CA, Sekar YS, Suresh KP, Subramaniam S, Sagar N, Rani S, Anandakumar J, Pandey RK, Barman NN, Patil SS., Free PMC Article

    05/28/2024
    Sex Hormone-regulated CMG2 Is Involved in Breast and Prostate Cancer Progression.

    Sex Hormone-regulated CMG2 Is Involved in Breast and Prostate Cancer Progression.
    Fang Z, Killick C, Halfpenny C, Frewer N, Frewer KA, Ruge F, Jiang WG, Ye L., Free PMC Article

    11/5/2022
    The Capillary Morphogenesis Gene 2 Triggers the Intracellular Hallmarks of Collagen VI-Related Muscular Dystrophy.

    The Capillary Morphogenesis Gene 2 Triggers the Intracellular Hallmarks of Collagen VI-Related Muscular Dystrophy.
    Castroflorio E, Pérez Berná AJ, López-Márquez A, Badosa C, Loza-Alvarez P, Roldán M, Jiménez-Mallebrera C., Free PMC Article

    08/6/2022
    Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations.

    Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations.
    Yamaguchi M, Hirai S, Idogawa M, Uchida H, Sakuma Y.

    07/30/2022
    Novel variation in ANTXR2 gene causing hyaline fibromatosis syndrome: A report from India.

    Novel variation in ANTXR2 gene causing hyaline fibromatosis syndrome: A report from India.
    Chaudhry C, Kaur P, Srivastava P, Panigrahi I, Kaur A.

    12/25/2021
    Multiple stages of evolutionary change in anthrax toxin receptor expression in humans.

    Multiple stages of evolutionary change in anthrax toxin receptor expression in humans.
    Choate LA, Barshad G, McMahon PW, Said I, Rice EJ, Munn PR, Lewis JJ, Danko CG., Free PMC Article

    12/18/2021
    Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension.

    Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension.
    Meng L, Yuan W, Chi H, Han R, Zhang Y, Pan X, Meng J, Liu Y, Song J, Zhong J, Liu X.

    07/24/2021
    Enhanced Collagen Deposition in the Duodenum of Patients with Hyaline Fibromatosis Syndrome and Protein Losing Enteropathy.

    Enhanced Collagen Deposition in the Duodenum of Patients with Hyaline Fibromatosis Syndrome and Protein Losing Enteropathy.
    van Rijn JM, Werner L, Aydemir Y, Spronck JMA, Pode-Shakked B, van Hoesel M, Shimshoni E, Polak-Charcon S, Talmi L, Eren M, Weiss B, H J Houwen R, Barshack I, Somech R, Nieuwenhuis EES, Sagi I, Raas-Rothschild A, Middendorp S, Shouval DS., Free PMC Article

    04/3/2021
    A Canstatin-Derived Peptide Provides Insight into the Role of Capillary Morphogenesis Gene 2 in Angiogenic Regulation and Matrix Uptake.

    A Canstatin-Derived Peptide Provides Insight into the Role of Capillary Morphogenesis Gene 2 in Angiogenic Regulation and Matrix Uptake.
    Finnell JG, Tsang TM, Cryan L, Garrard S, Lee SL, Ackroyd PC, Rogers MS, Christensen KA.

    02/13/2021
    Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis.

    Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis.
    Xu H, Qu Y., Free PMC Article

    08/13/2020
    Elevation of ANTXR2 promotes endometriotic cell adhesion, proliferation, and angiogenesis. Furthermore, hypoxia is the driving force for ANTXR2 upregulation via altering histone modification of ANTXR2.

    Targeting Anthrax Toxin Receptor 2 Ameliorates Endometriosis Progression.
    Lin SC, Lee HC, Hsu CT, Huang YH, Li WN, Hsu PL, Wu MH, Tsai SJ., Free PMC Article

    12/14/2019
    CMG2 is an indicator of poor prognosis of glioma patients and also a stimulator of cell cycle progression in cultured glioma cells.

    Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
    Tan J, Liu M, Zhang JY, Yao YL, Wang YX, Lin Y, Song K, Tan J, Wu JR, Cui YH, Wang Y, Bian XW.

    11/2/2019
    Study provides evidence to reinforce the previous hypothesis that missense mutations in exons 1-12 in ANTXR2 and mutations leading to a premature stop codon lead to the severe form of the disease, while missense pathogenic variants in exons 13-17 lead to the mild form of hyaline fibromatosis syndrome. [review]

    Hyaline fibromatosis syndrome: Clinical update and phenotype-genotype correlations.
    Casas-Alba D, Martínez-Monseny A, Pino-Ramírez RM, Alsina L, Castejón E, Navarro-Vilarrubí S, Pérez-Dueñas B, Serrano M, Palau F, García-Alix A.

    10/12/2019
    CMG2 promoted the invasion of glioma cells

    Promotive effects of capillary morphogenetic protein 2 on glioma cell invasion and the molecular mechanism.
    Xu Y, He Y, Xu W, Lu T, Liang W, Jin W.

    08/31/2019
    CMG2 promotes GC progression by maintaining GCSLCs and can serve as a new prognostic indicator and a target for human GC therapy.

    Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway.
    Ji C, Yang L, Yi W, Xiang D, Wang Y, Zhou Z, Qian F, Ren Y, Cui W, Zhang X, Zhang P, Wang JM, Cui Y, Bian X., Free PMC Article

    03/2/2019
    Results from hyaline fibromatosis syndrome (HFS) patients with consanguineous background identified a novel homozygous frameshift deletion c.969del (p.Ile323Metfs*14), a previously reported mutation c.134 T > C (p.Leu45Pro) and a recurrent homozygous frameshift mutation c.1073dup (p.Ala359Cysfs*13). These findings improves the understanding of a recurrent mutation in HFS.

    The genetic basis of hyaline fibromatosis syndrome in patients from a consanguineous background: a case series.
    Youssefian L, Vahidnezhad H, Touati A, Ziaee V, Saeidian AH, Pajouhanfar S, Zeinali S, Uitto J., Free PMC Article

    03/2/2019
    this study shows no association between ANTXR2 polymorphisms and ankylosing spondylitis susceptibility in a Chinese Han population, but meta-analysis showed that rs4389526 in the ANTXR2 gene was weakly associated with AS susceptibility in both Caucasian and Chinese Han patients.

    Case-Control Study and Meta-Analysis Show a Weak Association between ANTXR2 Polymorphisms and Ankylosing Spondylitis in Chinese Han.
    Hu J, Du L, Su W, Liu S, Deng J, Cao Q, Yuan G, Kijlstra A, Yang P., Free PMC Article

    01/12/2019
    A decreased CMG2 expression is a negative prognostic factor for soft tissue sarcoma patients.

    CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.
    Greither T, Wedler A, Rot S, Keßler J, Kehlen A, Holzhausen HJ, Bache M, Würl P, Taubert H, Kappler M., Free PMC Article

    07/28/2018
    Results identified Gly116Val mutation in ANTXR2 associated with hyaline fibromatosis syndrome.

    Diagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome.
    Haidar Z, Temanni R, Chouery E, Jithesh P, Liu W, Al-Ali R, Wang E, Marincola FM, Jalkh N, Haddad S, Haidar W, Chouchane L, Mégarbané A., Free PMC Article

    09/23/2017
    Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability

    Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
    Mamillapalli S, Miyagi M, Bann JG., Free PMC Article

    07/15/2017
    expression does not affect cytotoxicity to anthrax toxin

    ANTXR-1 and -2 independent modulation of a cytotoxicity mediated by anthrax toxin in human cells.
    Fujikura D, Toyomane K, Kamiya K, Mutoh M, Mifune E, Ohnuma M, Higashi H., Free PMC Article

    06/24/2017
    study examines 4 cases with clinical features of hyaline fibromatosis syndrome; identified a previously unreported splice junction mutation (c.946-2A-->G in intron 11) and a recurrent founder mutation ( c.1074delT)

    Hyaline Fibromatosis Syndrome: A Novel Mutation and Recurrent Founder Mutation in the CMG2/ANTXR2 Gene.
    Youssefian L, Vahidnezhad H, Aghighi Y, Ziaee V, Zeinali S, Abiri M, Uitto J.

    03/4/2017
    This study reports a novel association between ANTXR2 and ankylosing spondylitis in the Han Chinese.

    A complex role of anthrax toxin receptor 2 polymorphisms and capillary morphogenesis protein 2 in ankylosing spondylitis pathogenesis.
    Zhang Z, Yu K, Dai D, Yuan F, Liang F, Liu N, Xi Y, Sun YY.

    02/25/2017
    Case Report: systemic hyalinosis with a heterozygous mutation in CMG2.

    Systemic Hyalinosis With Heterozygous CMG2 Mutations: A Case Report and Review of Literature.
    Rahvar M, Teng J, Kim J.

    01/28/2017
    The association between ANTXR2 rs4333130 and ankylosing spondylitis was independent of HLA-B27 status. Clinical disease severity scores (BASDAI and BASFI) and pain score were higher in ANTXR2 rs4333130 CT genotype.

    Determination of IL1 R2, ANTXR2, CARD9, and SNAPC4 single nucleotide polymorphisms in Iranian patients with ankylosing spondylitis.
    Momenzadeh P, Mahmoudi M, Beigy M, Garshasbi M, Vodjdanian M, Farazmand A, Jamshidi AR.

    01/14/2017
    firstprevious page of 3 nextlast